|
|
Post by centralcoastinvestor on Jun 27, 2018 12:11:39 GMT -5
Dr. Kendall presentation is epic! Folks are asking questions even before presentation is done.
|
|
|
|
Post by peppy on Jun 27, 2018 12:17:14 GMT -5
|
|
|
|
Post by peppy on Jun 27, 2018 12:27:01 GMT -5
|
|
|
|
Post by peppy on Jun 27, 2018 12:36:19 GMT -5
MNKD has brought in people experienced with label changes. per Dr Kendall.
|
|
|
|
Post by peppy on Jun 27, 2018 12:37:09 GMT -5
aged, the question has been answered, all the hypoglycemic data seems to be from affinity.
|
|
|
|
Post by centralcoastinvestor on Jun 27, 2018 12:45:02 GMT -5
Lots of questions. Still going. This meeting may go past 2 hours.
|
|
|
|
Post by peppy on Jun 27, 2018 12:45:49 GMT -5
|
|
|
|
Post by dg1111 on Jun 27, 2018 12:46:08 GMT -5
Can anybody tell who is asking questions? I am having a hard time hearing the questions. I am trying to get a sense of which institutions are in attendance.
|
|
|
|
Post by awesomo on Jun 27, 2018 12:49:02 GMT -5
Keep firing those questions.
|
|
|
|
Post by peppy on Jun 27, 2018 12:52:25 GMT -5
Can anybody tell who is asking questions? I am having a hard time hearing the questions. I am trying to get a sense of which institutions are in attendance. attendees |
|
|
|
Post by peppy on Jun 27, 2018 12:54:53 GMT -5
nice conference
|
|
|
|
Post by centralcoastinvestor on Jun 27, 2018 12:57:33 GMT -5
Meeting just finished. Just under two hours. Very good prestentations designed to help analysts understand what Afrezza is and how disruptive its going to be. I sure hope we see one or two bigger analysts begin covering again.
|
|
|
|
Post by akemp3000 on Jun 27, 2018 13:00:31 GMT -5
I lost count of every time Dr. Kendall used the phrase "significantly better" when discussing the STAT study. Glad he slammed the door on the idea that the results weren't that significant.
|
|
|
|
Post by bill on Jun 27, 2018 13:08:50 GMT -5
I lost count of every time Dr. Kendall used the phrase "significantly better" when discussing the STAT study. Glad he slammed the door on the idea that the results weren't that significant. Now the question is whether the endos and investment community will just ignore everything presented at the ADA conference and this call, or act on it... |
|
|
|
Post by oldfishtowner on Jun 27, 2018 13:10:41 GMT -5
"Technosphere insulin superior." Dr. Kendall. Kendall gave a "time in range"/hbA1c equation calculation.  The first data point on Kendall's slide shows that 2 groups starting at the same BG level. The fact that this data point was missing in the Improved PPBG STAT paper abstract concerned me. Kendall cleared up a number of other questions I had and certainly made a stronger case for improved PPBG and TIR with Afrezza than just looking at the abstracts did for me. |
|
